Transitioning to Ready-to-Administer IV Medications: Can it be Both Safe and Affordable?

Medication errors associated with the administration of the wrong dose and/or wrong concentration are believed to be more prevalent when frontline practitioners are provided with a parenteral product that requires additional manipulation (partial doses, reconstitution, or dilution) at the bedside. In one study of IV medication administration errors, four error types (wrong diluent mixture, wrong diluent volume, wrong “bolus” rate, and drug incompatibility) accounted for over 91% of the errors; 27% of these errors were considered serious.

Learn about key vulnerabilities when intravenous (IV) medications that require manipulation at the bedside have led to errors and patient harm. The speakers will also discuss cost and safety comparisons of manufacturer-prepared prefilled ready-to-administer (RTA) products versus traditional vial-to-syringe products.

Objectives:

• Describe the risks associated with the preparation and administration of IV medications that are manipulated at the bedside.
• Compare studies evaluating the cost and safety comparisons between manufacturer-prepared prefilled ready-to administer (RTA) products versus traditional vial-and-syringe products.
• Describe savings and improved safety from transitioning from traditional vial-and-syringe medications to manufacturer-prepared prefilled ready-to-administer (RTA) products.

The program is supported by Fresenius Kabi and continuing education (CE) credit is being offered for pharmacists, pharmacy technicians, and nurses.

For more information and to register, please click here.